On-Demand Webinar

Quantitative 3D Whole-Brain Mapping of Sex-Specific Amyloid Pathology in the APP-PS1 (ARTE10) Mouse Model

About the webinar:

Alzheimer’s disease is the most common cause of dementia. It is associated with the build-up of small protein aggregates in the brain, termed β-amyloid plaques, ultimately leading to brain damage and memory loss. Overall, more women are affected by Alzheimer’s disease than men, but the reasons for these differences are not fully understood. Elucidating these differences is crucial for improving therapies aimed at reducing the detrimental impact of β-amyloid plaque buildup.

This study aimed to investigate sex-specific β-amyloid plaque dynamics in a female and male transgenic mouse model of Alzheimer’s disease. To enable this, we employed 3-dimensional imaging to map and quantify β-amyloid plaques throughout the intact mouse brain at different ages. We found that female transgenic mice develop β-amyloid plaques earlier and show a more rapid and widespread accumulation than their male counterparts in almost all parts of the brain.

In conclusion, our study provides the first quantitative assessment of sex differences in progressive β-amyloid plaque pathology across the entire brain in a mouse model of Alzheimer’s disease, offering insights that may guide future research and inform the development of sex-specific treatment strategies.

Why Taconic?

Taconic Biosciences is a global leader in genetically engineered mouse models and colony management services. We support researchers in advancing their science with innovative, reliable solutions. 

Learn More about our Fully Integrated Custom Model Generation and Colony Management Solutions.


Scientific Poster

3D Whole-Brain Imaging in Collaboration with Gubra Reveals Sex-Dependent Amyloidosis in APP-PS1 (ARTE10) Mouse Model

Learn how Taconic and Gubra use 3D imaging to characterize parenchymal and vascular Aβ plaques in APP-PS1 (ARTE10) mice, informing preclinical Alzheimer’s research design.

View the Webinar

Meet the Team


Yasir

Speaker:

Yasir Gallero-Salas, PhD  LinkedIn

Senior Scientist | Gubra

Dr. Yasir Gallero-Salas is a Senior Scientist at Gubra ApS in the department of 3D imaging. Originally trained as a biologist at the University of Malaga (Spain), he then pursued his interest in the neural basis of behaviour as a PhD student at the University of Zurich. There, he applied several microscopy techniques to study how mice brains encode short-term memory. After starting his own family, he decided to move to Copenhagen and apply his microscopy skills at Gubra, a biotech company. Since 2021, he has been using 3D microscopy to boost drug discovery for neurological diseases.


Jessica Ramadhin

Moderator:

Sarah Sterlace, PhD LinkedIn

Director, Portfolio Management Neurobiology and Rare Disease

Dr. Sarah Sterlace joined Taconic in 2024 and is currently Director of Portfolio Management focusing on Neurobiology and Rare Disease.  Sarah has more than 10 years of experience in drug discovery and life sciences support with an emphasis in emerging technologies and customer-focused solutions for advancing translational research.